Representation and Extrapolation: Evidence from Clinical Trials
The Quarterly Journal of Economics · 08.01.2024 · 139 (1) · 575-635
DOI: 10.1093/qje/qjad036 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Quarterly Journal of Economics, online erschienen am 05.09.2023. Verfasst von Marcella Alsan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Kennedy School and National Bureau of Economic Research, United States. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, U.S. Food and Drug Administration, Harvard University.
Abstract (Originalsprache)
This article examines the consequences and causes of low enrollment of Black patients in clinical trials. We develop a simple model of similarity-based extrapolation that predicts that evidence is more relevant for decision-making by physicians and patients when it is more representative of the group being treated. This generates the key result that the perceived benefit of a medicine for a group depends not only on the average benefit from a trial but also on the share of patients from that group who were enrolled in the trial. In survey experiments, we find that physicians who care for Black patients are more willing to prescribe drugs tested in representative samples, an effect substantial enough to close observed gaps in the prescribing rates of new medicines. Black patients update more on drug efficacy when the sample that the drug is tested on is more representative, reducing Black-white patient gaps in beliefs about whether the drug will work as described. Despite these benefits of representative data, our framework and evidence suggest that those who have benefited more from past medical breakthroughs are less costly to enroll in the present, leading to persistence in who is represented in the evidence base.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Harvard Kennedy School and National Bureau of Economic Research, United States.
- Stanford University, United States.
- Harvard Business School, United States.
- Stanford University and National Bureau of Economic Research, United States.
Förderung
- NIA NIH HHS
- U.S. Food and Drug Administration
- Harvard University
- AEA
- National Science Foundation
- MacArthur Foundation
Zitieren
APA
Alsan, M., Durvasula, M., Gupta, H., Schwartzstein, J., & Williams, H. (2024). Representation and Extrapolation: Evidence from Clinical Trials. The Quarterly Journal of Economics, 139(1), 575-635. https://doi.org/10.1093/qje/qjad036
Vancouver
Alsan M, Durvasula M, Gupta H, Schwartzstein J, Williams H. Representation and Extrapolation: Evidence from Clinical Trials. The Quarterly Journal of Economics. 2024;139(1):575-635. doi:10.1093/qje/qjad036
BibTeX
@article{Alsan2024,
author = {Alsan, Marcella and Durvasula, Maya and Gupta, Harsh and Schwartzstein, Joshua and Williams, Heidi},
title = {Representation and Extrapolation: Evidence from Clinical Trials},
journal = {The Quarterly Journal of Economics},
year = {2024},
volume = {139},
number = {1},
pages = {575--635},
doi = {10.1093/qje/qjad036}
}
EUVIMED